Reata Pharmaceuticals Volatility
| RETADelisted Stock | USD 109.67 3.31 2.93% |
We have found thirty technical indicators for Reata Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Reata Pharmaceuticals' Semi Deviation of 3.31, coefficient of variation of 1897.93, and Risk Adjusted Performance of 0.0484 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to Reata Pharmaceuticals' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Reata Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Reata daily returns, and it is calculated using variance and standard deviation. We also use Reata's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Reata Pharmaceuticals volatility.
Reata |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Reata Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Reata Pharmaceuticals at lower prices to lower their average cost per share. Similarly, when the prices of Reata Pharmaceuticals' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving against Reata Stock
| 0.82 | PBCRY | Bank Central Asia | PairCorr |
| 0.64 | BKRKY | Bank Rakyat | PairCorr |
| 0.63 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.63 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.6 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.57 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
| 0.51 | PBCRF | PT Bank Central | PairCorr |
| 0.46 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.45 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
Reata Pharmaceuticals Market Sensitivity And Downside Risk
Reata Pharmaceuticals' beta coefficient measures the volatility of Reata stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Reata stock's returns against your selected market. In other words, Reata Pharmaceuticals's beta of 0.76 provides an investor with an approximation of how much risk Reata Pharmaceuticals stock can potentially add to one of your existing portfolios. Reata Pharmaceuticals shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Reata Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Reata Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Reata Pharmaceuticals Demand TrendCheck current 90 days Reata Pharmaceuticals correlation with market (Dow Jones Industrial)Reata Beta |
Reata standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.0 |
It is essential to understand the difference between upside risk (as represented by Reata Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Reata Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in reata stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Reata Pharmaceuticals.
Reata Pharmaceuticals Stock Volatility Analysis
Volatility refers to the frequency at which Reata Pharmaceuticals delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Reata Pharmaceuticals' price changes. Investors will then calculate the volatility of Reata Pharmaceuticals' stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Reata Pharmaceuticals' volatility:
Historical Volatility
This type of delisted stock volatility measures Reata Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Reata Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Reata Pharmaceuticals' current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Reata Pharmaceuticals' to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Reata Pharmaceuticals Projected Return Density Against Market
Given the investment horizon of 90 days Reata Pharmaceuticals has a beta of 0.7644 indicating as returns on the market go up, Reata Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Reata Pharmaceuticals will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Reata Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Reata Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Reata delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Reata Pharmaceuticals has an alpha of 0.1074, implying that it can generate a 0.11 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Reata Pharmaceuticals Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Reata Pharmaceuticals Stock Return Volatility
Reata Pharmaceuticals historical daily return volatility represents how much of Reata Pharmaceuticals delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7444% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Reata Pharmaceuticals Volatility
Volatility is a rate at which the price of Reata Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Reata Pharmaceuticals may increase or decrease. In other words, similar to Reata's beta indicator, it measures the risk of Reata Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Reata Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. Reata Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Plano, Texas. Reata Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 346 people.
Reata Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Reata Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Reata Pharmaceuticals' price varies over time.
3 ways to utilize Reata Pharmaceuticals' volatility to invest better
Higher Reata Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Reata Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Reata Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Reata Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Reata Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Reata Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Reata Pharmaceuticals Investment Opportunity
Dow Jones Industrial has a standard deviation of returns of 0.74 and is 9.223372036854776E16 times more volatile than Reata Pharmaceuticals. 0 percent of all equities and portfolios are less risky than Reata Pharmaceuticals. You can use Reata Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Reata Pharmaceuticals to be traded at $105.28 in 90 days.Average diversification
The correlation between Reata Pharmaceuticals and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Reata Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Reata Pharmaceuticals Additional Risk Indicators
The analysis of Reata Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Reata Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Reata Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0484 | |||
| Market Risk Adjusted Performance | 0.2659 | |||
| Mean Deviation | 2.22 | |||
| Semi Deviation | 3.31 | |||
| Downside Deviation | 3.56 | |||
| Coefficient Of Variation | 1897.93 | |||
| Standard Deviation | 3.9 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Reata Pharmaceuticals Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Reata Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Reata Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Reata Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Reata Pharmaceuticals.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Reata Stock
If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |